Exciting Update! The shipment is underway. Our acellular pertussis vaccines (aP) are officially on the move, heading to support the Universal Coverage Scheme in gold card benefit package, managed by National Health Security Office (NHSO). This demonstrates our strong commitment to protecting mothers and babies from pertussis in Thailand.
According to the Department of Disease Control (DDC) report, the situation concerning pertussis in 2023 unveiled a rising outbreak in the southern region, particularly impacting unvaccinated children, including newborns who are too young to receive immunization. Preventing pertussis can provide immunity to children through the vaccination of pregnant women.

BioNet News

Welcome New BioNet Scientific Advisory Board Members

Dr. Norbert Pardi
Prof. Peter Openshaw (via Imperial Consultants)
Dr William Gruber

BioNet Tube

Biotech News

Join BioNet Team?

We are currently seeking new candidates to fill open positions in our highly skilled team.

Collaborative Networks

With the belief that sharing vaccine expertise can accelerate the development of new technologies and the access to vaccines, we have been building bio-clusters and alliances with public and private organizations.